Bryan Reasons Joins Mallinckrodt as the Company's Chief Financial Officer (CFO)

Brings substantial CFO, finance expertise and pharmaceutical industry experience STAINES-UPON-THAMES, United Kingdom, March 18, 2019 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical co... Biopharmaceuticals, Personnel Mallinckrodt
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news